Loading…
Sectoral / Thematic · Nippon India Mutual Fund · AMFI code 102431Nippon India Pharma Fund
Disclosed for 84 months, Sep 2019 to Aug 2026.Published as: NIPPON INDIA PHARMA FUND (An Open Ended Equity Scheme Investing In Pharma Sector)
Portfolio value
₹4,564 Cr
up ₹53.7 Cr vs Apr 2023
- Stocks held
- 29
- unchanged
- Top 10 weight
- 58.0%
- of the portfolio in its ten largest
- Cash & debt
- 2.0%
- cash, money market and debt
- Moves this month
- 0 in · 0 out
- added to 10, trimmed 10
Nippon India Pharma Fund is an active equity fund in the Sectoral / Thematic category from Nippon India Mutual Fund. In May 2023 it disclosed 29 stocks worth ₹4,564 Cr, up ₹53.7 Cr from Apr 2023. Its largest positions were Sun Pharmaceutical Industries Limited (14.0%), Lupin Limited (7.1%), Cipla Limited (6.3%); the ten largest together made up 58.0% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 76.3% of its equity. Cash and debt stood at 2.0%. Compared with Apr 2023 the fund entered 0 new stocks and exited 0.
Against 226 other Sectoral / Thematic funds
Concentration
79%
Top-10 weight is higher than 79% of peers
Breadth
12%
Holds more stocks than 12% of peers
Cash
30%
Holds more cash than 30% of peers
Holdings in May 2023
Download CSVEvery line the fund disclosed, with the change against Apr 2023. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 14.01%
- Δ weight
- down 0.35 pts
- Value
- ₹639 Cr
- Δ value
- down ₹8.1 Cr
- Status
- Trimmed
- Weight
- 7.06%
- Δ weight
- up 0.13 pts
- Value
- ₹322 Cr
- Δ value
- up ₹9.7 Cr
- Status
- Added
- Weight
- 6.26%
- Δ weight
- up 0.22 pts
- Value
- ₹286 Cr
- Δ value
- up ₹13.5 Cr
- Status
- Added
- Weight
- 5.42%
- Δ weight
- down 1.68 pts
- Value
- ₹248 Cr
- Δ value
- down ₹72.9 Cr
- Status
- Trimmed
- Weight
- 5.29%
- Δ weight
- up 0.58 pts
- Value
- ₹241 Cr
- Δ value
- up ₹28.9 Cr
- Status
- Added
- Weight
- 4.33%
- Δ weight
- up 0.23 pts
- Value
- ₹198 Cr
- Δ value
- up ₹12.5 Cr
- Status
- Added
- Weight
- 4.31%
- Δ weight
- up 0.10 pts
- Value
- ₹197 Cr
- Δ value
- up ₹7 Cr
- Status
- Added
- Weight
- 4.19%
- Δ weight
- down 1.02 pts
- Value
- ₹191 Cr
- Δ value
- down ₹43.7 Cr
- Status
- Trimmed
- Weight
- 3.64%
- Δ weight
- down 0.63 pts
- Value
- ₹166 Cr
- Δ value
- down ₹26.6 Cr
- Status
- Trimmed
- Weight
- 3.52%
- Δ weight
- down 0.17 pts
- Value
- ₹161 Cr
- Δ value
- down ₹5.6 Cr
- Status
- Trimmed
- Weight
- 3.51%
- Δ weight
- up 0.76 pts
- Value
- ₹160 Cr
- Δ value
- up ₹36.3 Cr
- Status
- Added
- Weight
- 3.50%
- Δ weight
- down 0.08 pts
- Value
- ₹160 Cr
- Δ value
- down ₹1.9 Cr
- Status
- Trimmed
- Weight
- 3.41%
- Δ weight
- up 1.39 pts
- Value
- ₹156 Cr
- Δ value
- up ₹64.7 Cr
- Status
- Added
- Weight
- 3.25%
- Δ weight
- up 2.78 pts
- Value
- ₹148 Cr
- Δ value
- up ₹127 Cr
- Status
- Added
- Weight
- 3.23%
- Δ weight
- up 0.89 pts
- Value
- ₹148 Cr
- Δ value
- up ₹41.7 Cr
- Status
- Added
- Weight
- 3.12%
- Δ weight
- up 0.12 pts
- Value
- ₹143 Cr
- Δ value
- up ₹7.2 Cr
- Status
- Added
- Weight
- 2.96%
- Δ weight
- down 0.17 pts
- Value
- ₹135 Cr
- Δ value
- down ₹6 Cr
- Status
- Trimmed
- Weight
- 2.83%
- Δ weight
- down 0.04 pts
- Value
- ₹129 Cr
- Δ value
- down ₹43 L
- Status
- Held
- Weight
- 2.44%
- Δ weight
- up <0.01 pts
- Value
- ₹111 Cr
- Δ value
- up ₹1.4 Cr
- Status
- Added
- Weight
- 2.43%
- Δ weight
- down 0.58 pts
- Value
- ₹111 Cr
- Δ value
- down ₹25 Cr
- Status
- Trimmed
- Weight
- 2.43%
- Δ weight
- down 1.61 pts
- Value
- ₹111 Cr
- Δ value
- down ₹71.1 Cr
- Status
- Trimmed
- Cash, TREPS & receivables
- Weight
- 2.05%
- Δ weight
- down 1.19 pts
- Value
- ₹93.3 Cr
- Δ value
- down ₹52.5 Cr
- Status
- Trimmed
- Weight
- 1.75%
- Δ weight
- up 0.02 pts
- Value
- ₹79.9 Cr
- Δ value
- up ₹1.9 Cr
- Status
- Added
- Weight
- 1.42%
- Δ weight
- up 0.10 pts
- Value
- ₹64.6 Cr
- Δ value
- up ₹5.3 Cr
- Status
- Added
- Weight
- 1.27%
- Δ weight
- up 0.07 pts
- Value
- ₹58.1 Cr
- Δ value
- up ₹3.8 Cr
- Status
- Added
- Weight
- 0.91%
- Δ weight
- up 0.04 pts
- Value
- ₹41.6 Cr
- Δ value
- up ₹2.4 Cr
- Status
- Added
- Weight
- 0.51%
- Δ weight
- up 0.02 pts
- Value
- ₹23.5 Cr
- Δ value
- up ₹1.1 Cr
- Status
- Added
- Weight
- 0.40%
- Δ weight
- up 0.02 pts
- Value
- ₹18.2 Cr
- Δ value
- up ₹1 Cr
- Status
- Added
- Weight
- 0.28%
- Δ weight
- up 0.04 pts
- Value
- ₹12.6 Cr
- Δ value
- up ₹1.8 Cr
- Status
- Added
- Weight
- 0.27%
- Δ weight
- down 0.01 pts
- Value
- ₹12.4 Cr
- Δ value
- down ₹15 L
- Status
- Trimmed
What changed, Apr 2023 to May 2023
New New positions (0)
None.
Exited Exited (0)
None.
Added Biggest additions
- Mankind Pharma Limitedup ₹127 Cr (+2.78% pts)
- MedPlus Health Services Limitedup ₹64.7 Cr (+1.39% pts)
- Vijaya Diagnostic Centre Limitedup ₹41.7 Cr (+0.89% pts)
- Sanofi India Limitedup ₹36.3 Cr (+0.76% pts)
- Divi's Laboratories Limited ₹28.9 Cr (+0.58% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Apr 2023, the weight rose most in Retailing (+1.4 pts), and fell most in Pharmaceuticals & Biotechnology (−1.5 pts).
- Retailing2.1% → 3.5%+1.4 pts
- Pharmaceuticals & Biotechnology77.7% → 76.3%−1.5 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | May 2020 | May 2022 | Nov 2022 | Feb 2023 | Apr 2023 | May 2023 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 80.3% | 79.9% | 78.5% | 76.8% | 77.7% | 76.3% |
| Healthcare Services | 17.4% | 17.7% | 19.5% | 19.7% | 18.5% | 18.5% |
| Retailing | — | — | 0.1% | 1.6% | 2.1% | 3.5% |
| Pharmaceuticals | 2.3% | 1.8% | 1.5% | 1.6% | 1.4% | 1.4% |
| Healthcare Equipment & Supplies | — | 0.6% | 0.3% | 0.3% | 0.3% | 0.3% |
Allocation in May 2023change vs Apr 2023
- Pharmaceuticals & Biotechnology (19)76.3%▼ 1.5 pts
- Healthcare Services (7)18.5%
- Retailing (1)3.5%▲ 1.4 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, May 2023
2.0%
▼ 1.2 pts vs Apr 2023
- Cash alone
- 2.0%
- cash and net receivables
- A year earlier
- 1.7%
- May 2022 · now ▲ 0.4 pts
- Last 12 months
- 0.3% – 3.2%
- lowest to highest · record 5.9% in May 2021
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.